Patents Assigned to MedRegen, LLC
  • Methods of treating inflammatory bowel disease with AMD3100 and Tacrolimus
    Patent number: 11291657
    Abstract: The present invention relates to the field of inflammatory bowel disease. In one aspect, the present invention provides methods for treating inflammatory bowel disease in a patient comprising administering to the patient a therapeutically effective amount of a stem cell mobilizer and an immunosuppressive agent. In particular embodiments, the present invention provides a method for treating inflammatory bowel disease in a patient comprising administering to the patient a therapeutically effective amount of an agent that mobilizes CD34+ and/or CD133+ stem cells and a low dose of an immunosuppressive agent.
    Type: Grant
    Filed: August 14, 2019
    Date of Patent: April 5, 2022
    Assignee: Medregen, LLC
    Inventors: Zhaoli Sun, Xuhang Li
  • Methods of recruiting SDF-producing macrophages
    Patent number: 10945993
    Abstract: The present invention relates to the field of wound healing. More specifically, the present invention provides methods and compositions useful for improved wound healing via autologous stem cell mobilization. In one embodiment, a method for improving wound healing in a patient comprises administering to the patient a therapeutically effective amount of a stem cell mobilizer and a low dose of an immunosuppressive agent.
    Type: Grant
    Filed: April 29, 2014
    Date of Patent: March 16, 2021
    Assignee: MedRegen, LLC
    Inventors: Zhaoli Sun, George Melville Williams, Qing Lin
  • Treatment methods utilizing stem cell mobilizers and immunosuppressive agents
    Patent number: 10813917
    Abstract: The present invention relates to the field of organ transplantation. In one aspect, the present invention provides methods of treating an organ transplant recipient comprising administering to the recipient a therapeutically effective amount of a stem cell mobilizer and an immunosuppressive agent. In particular embodiments, the present invention provides a method of treating an organ transplant recipient comprising administering to the recipient a therapeutically effective amount of an agent that mobilizes CD34+ and/or CD133+ stem cells and a low dose of an immunosuppressive agent.
    Type: Grant
    Filed: December 10, 2010
    Date of Patent: October 27, 2020
    Assignee: MedRegen, LLC
    Inventors: Zhaoli Sun, George Melville Williams
  • Methods of treating inflammatory bowel disease with AMD3100 and tacrolimus
    Patent number: 10420751
    Abstract: The present invention relates to the field of inflammatory bowel disease. In one aspect, the present invention provides methods for treating inflammatory bowel disease in a patient comprising administering to the patient a therapeutically effective amount of a stem cell mobilizer and an immunosuppressive agent. In particular embodiments, the present invention provides a method for treating inflammatory bowel disease in a patient comprising administering to the patient a therapeutically effective amount of an agent that mobilizes CD34+ and/or CD133+ stem cells and a low dose of an immunosuppressive agent.
    Type: Grant
    Filed: July 31, 2015
    Date of Patent: September 24, 2019
    Assignee: MedRegen, LLC
    Inventors: Zhaoli Sun, Xuhang Li